bioanalysis of biopharmaceuticals and biomarkers by liquid ...€¦ · 15/03/2019 · in vivo...
TRANSCRIPT
![Page 1: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/1.jpg)
faculty of science and engineering analytical biochemistry
Rainer Bischoffwww.biomac.nl
| 1
Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid Chromatography –
Mass Spectrometry
Dublin/Ireland, March 15, 2019
![Page 2: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/2.jpg)
European Research Institute: Biology of Ageing
• Ligand Binding Assays (LBAs) versus LC-MS Assays: two sides of the same
coin?
• In vivo biotransformation of Trastuzumab
• LC-high-resolution mass spectrometry in protein bioanalysis
• Targeted biomarker analysis by LC-MS at the pM level with and without affinity
enrichment
![Page 3: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/3.jpg)
Ligand Binding Assays (LBAs) and LC-MS Assays
3
![Page 4: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/4.jpg)
Are they two sides of the same coin?
![Page 5: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/5.jpg)
LBAs may be affected by competition for binding
![Page 6: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/6.jpg)
Zhang et al. Anal Chem, 86, 8776-8784 (2014)
LC-MS versus ELISA
![Page 7: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/7.jpg)
Fischer et al. mAbs, 4, 623-631 (2012)
Different Immunocapture Agents
MAC: monoclonal antibodyPAC: polyclonal antibody
![Page 8: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/8.jpg)
In vivo Processing/Degradation
Furlong, et al. Biomedical Chromatography, 26, 1024-1032 (2012)
![Page 9: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/9.jpg)
Hall, Drug metabolism and disposition: the biological fate of chemicals 2014, 42, 1873-1880.
In vivo Biotransformation of Biopharmaceuticals
![Page 10: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/10.jpg)
Kang et al., Anal. Chem. 2017, 89, 6065-6075.
In vivo Biotransformation analyzed by LC-MS
![Page 11: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/11.jpg)
The Trastuzumab-Her2 Complex
11
![Page 12: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/12.jpg)
Deamidation of Trastuzumab
12Bischoff & Kolbe, J. Chrom. B, 662, 261-278 (1994)
-Val-Tyr-Pro-
O
NH2
O
HN
Ala
O
-NH3
N
O
O OO
O-
O
HN
O
O
NH
O
O-
O
L-Asn-peptide
L-Asp-peptide L-isoAsp-peptideL-Imide-peptide
+H2O+H2O
![Page 13: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/13.jpg)
Selection of Signature Peptides
13
![Page 14: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/14.jpg)
Probing Deamidation at Asn55
14Bults et al., Anal Chem 2016, 88, 1871-1877.
![Page 15: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/15.jpg)
Forced Stability Study in Plasma
15Bults et al., Anal Chem 2016, 88, 1871-1877.
![Page 16: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/16.jpg)
Comparison LC-MS vs. ELISA
16Bults et al., Anal Chem 2016, 88, 1871-1877.
![Page 17: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/17.jpg)
In vivo Biotransformation
17Bults et al., Anal Chem 2016, 88, 1871-1877.
![Page 18: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/18.jpg)
Patient-Specific Deamidation
18Bults et al., Anal Chem 2016, 88, 1871-1877.
![Page 19: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/19.jpg)
https://medicine.yale.edu/keck/nida/targetedproteomics/introduction.aspx
![Page 20: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/20.jpg)
20
0.5 Da 0.07 Da 0.01 Da
Bults et al., Bioanalysis 2018, 10, 1009-1021.
![Page 21: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/21.jpg)
21Bults et al., Bioanalysis 2018, 10, 1009-1021.
![Page 22: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/22.jpg)
22Bults et al., Bioanalysis 2018, 10, 1009-1021.
LC-HRMS LC-MS
![Page 23: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/23.jpg)
23Bults et al., J. Chromatogr. B 2019, https://doi.org/10.1016/j.jchromb.2019.01.032
Charge state envelope deconvolution and isotopologue resolution
![Page 24: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/24.jpg)
Bults et al., J. Chromatogr. B 2019, https://doi.org/10.1016/j.jchromb.2019.01.032
Charge state envelope deconvolution and isotopologues resolution
![Page 25: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/25.jpg)
25Bults et al., J. Chromatogr. B 2019, https://doi.org/10.1016/j.jchromb.2019.01.0
![Page 26: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/26.jpg)
26An et al., mAbs 2014, 6, 879-893.
![Page 27: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/27.jpg)
27Bults et al., J. Chromatogr. B 2019, https://doi.org/10.1016/j.jchromb.2019.01.032
![Page 28: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/28.jpg)
28Bults et al., J. Chromatogr. B 2019, https://doi.org/10.1016/j.jchromb.2019.01.032
m-nitrobenzylalcohol (NBA)
![Page 29: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/29.jpg)
29Bults et al., J. Chromatogr. B 2019, https://doi.org/10.1016/j.jchromb.2019.01.032 Thompson et al., Methods 2014, 65, 11-17.
![Page 30: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/30.jpg)
Targeted Biomarker Analysis by LC-MS at the pM Level
Chronic Obstructive Pulmonary Disease (COPD)
![Page 31: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/31.jpg)
Pink Puffer Blue Bloater
Phenotypes of COPD
![Page 32: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/32.jpg)
Need for COPD Biomarkers
![Page 33: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/33.jpg)
How to Prioritize a Biomarker for COPD?
Ongay et al., Advances in Precision Medicine 2016, 1, 12-24.
![Page 34: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/34.jpg)
Expression of the AGER Gene
Fagerberg et al., Molecular & Cellular Proteomics 2014, 13, 397-406.
![Page 35: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/35.jpg)
Receptor for Advanced Glycation Endproducts (RAGE)
35
sRAGE
![Page 36: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/36.jpg)
Enrichment of sRAGE from Serum
36Klont et al., Talanta, 182, 2018, 414-421.
![Page 37: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/37.jpg)
Comparison: Immunoaffinity LC-MS vs. ELISA
Klont et al., Talanta, 182, 2018, 414-421.
![Page 38: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/38.jpg)
Alternative Affinity Agents: Affimers
Tiede et al., Elife 2017, 6, e24903.38
![Page 39: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/39.jpg)
Affimer-Based Enrichment vs. Antibody-Based Enrichment (1)
39Klont et al., J. Proteome Res., 8, 2018, 2892-2899
![Page 40: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/40.jpg)
40
Affimer-based Enrichment vs. Antibody-based Enrichment (2)
Klont et al., J. Proteome Res., 8, 2018, 2892-2899
![Page 41: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/41.jpg)
41Fritz, Trends Biochem Sci. 2011;36, 625-632.
sRAGE Enrichment Without Affinity Ligands
![Page 42: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/42.jpg)
42
Enrichment of sRAGE by Ion-Exchange SPE
Klont et al., Anal. Chim. Acta, 2018, 1043, 45-51
![Page 43: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/43.jpg)
SCX-SPE at pH 10
43Klont et al., Anal. Chim. Acta, 2018, 1043, 45-51
![Page 44: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/44.jpg)
44
LC-MS of sRAGE in Serum after SCX-SPE
Klont et al., Anal. Chim. Acta, 2018, 1043, 45-51
Imunoaffinity
Immunoaffinity SCX-SPE SCX-SPE + TCA
![Page 45: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/45.jpg)
45Pouwels et al., Am. J. Respir. Dis. Crit. Care Med., 2018, 198, 1456-1458
![Page 46: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/46.jpg)
46Pouwels et al., Am. J. Respir. Dis. Crit. Care Med., 2018, 198, 1456-1458
![Page 47: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/47.jpg)
47
• Proteins must be treated as family of molecules. Different ‘proteoforms’ may
respond differently in LC-MS and in Ligand Binding Assays.
• Endogenous interaction partners (e.g. antibodies, binding proteins) may
interfere with affinity-based enrichment strategies prior to LC-MS or Ligand
Binding Assays.
• In vivo biotransformation of therapeutic proteins will likely affect their
pharmacology. This may be different from one patient to another and should
be monitored.
• Low levels of biomarkers may be analyzed by LC-MS using different affinity
agents but also after more generic sample preparation.
Summary & Conclusions
![Page 48: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/48.jpg)
Acknowledgements
![Page 49: Bioanalysis of Biopharmaceuticals and Biomarkers by Liquid ...€¦ · 15/03/2019 · In vivo Biotransformation of Biopharmaceuticals. Kang et al., Anal. Chem. 2017, 89, 6065-6075](https://reader033.vdocument.in/reader033/viewer/2022050609/5fb0ab82f36d2644103a3344/html5/thumbnails/49.jpg)
49
Thank you for your attention!